Detecting Cancer Mutations with High-Resolution DNA Melting Analysis
Author Information
Author(s): Gonzalez-Bosquet Jesus, Calcei Jacob, Wei Jun S., Garcia-Closas Montserrat, Sherman Mark E., Hewitt Stephen, Vockley Joseph, Lissowska Jolanta, Yang Hannah P., Khan Javed, Chanock Stephen
Primary Institution: National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA
Hypothesis
The study aims to assess the sensitivity and specificity of high-resolution melting (HRM) analysis for tumor mutation screening in various cancer samples.
Conclusion
HRM analysis is a promising moderate-throughput screening test for mutations among known candidate genomic regions, with better accuracy in frozen specimens compared to paraffin-embedded samples.
Supporting Evidence
- The sensitivity and specificity of HRM analysis for frozen samples were 97% and 87%, respectively.
- For paraffin-embedded samples, the sensitivity and specificity were 88% and 80%, respectively.
- Overall accuracy of HRM analysis was better in frozen specimens compared to paraffin-embedded samples.
Takeaway
This study shows that a special test can help find changes in cancer DNA, which can help doctors understand and treat cancer better.
Methodology
The study used high-resolution melting analysis to screen for mutations in DNA extracted from frozen and paraffin-embedded tumor samples, followed by bi-directional sequencing for accuracy.
Limitations
The study faced challenges with lower sensitivity and specificity in paraffin-embedded samples compared to frozen samples, and some assays had high failure rates in sequencing.
Participant Demographics
The study included 216 frozen pediatric tumors and 180 paraffin-embedded tumors from breast, endometrial, and ovarian cancers.
Statistical Information
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website